Medical device development and management increasingly means treating medical devices as technology systems where software is a core component of their value proposition.  Developing software for medical devices has some very specific challenges in the face of Design Controls, 21 CFR Part 11, ISO 13485, and GxPs.  Achieving FDA clearance and sustaining your marketability means satisfying these requirements efficiently and cost effectively.

MethodSense can accelerate your go-to-market strategy by ensuring your medical device development life cycle systematically meets your documentation and regulatory needs.  MethodSense can help your development team:

• Comply with 21 CFR Part 11
• Qualify for ISO 13485
• Optimize your software development methodology
• Efficiently meet your validation requirements
• Create a practical development quality framework for meeting Design Control needs